Sabra Healthcare REIT (SBRA) Projected to Post Quarterly Earnings on Monday

Key Points

• Sabra Healthcare REIT is expected to release its Q2 2025 earnings on August 4th, with analysts predicting earnings of $0.37 per share and revenue of $185.64 million.
• The firm recently announced a quarterly dividend of $0.30 per share, resulting in a yield of 6.59% and indicating a payout ratio of 203.39%.
• Scotiabank has upgraded Sabra Healthcare REIT's price target from $19.00 to $20.00, reflecting a "sector perform" rating based on the stock's recent performance.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Monday, August 4th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $185.64 million for the quarter. Sabra Healthcare REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The firm had revenue of $183.54 million for the quarter, compared to the consensus estimate of $180.23 million. During the same period in the previous year, the firm posted $0.35 earnings per share. The firm's revenue was up 10.1% on a year-over-year basis. On average, analysts expect Sabra Healthcare REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Stock Up 0.5%

SBRA traded up $0.09 on Thursday, reaching $18.05. 966,345 shares of the company traded hands, compared to its average volume of 2,406,111. The stock's 50 day moving average price is $18.11 and its 200-day moving average price is $17.48. Sabra Healthcare REIT has a 52-week low of $15.60 and a 52-week high of $20.03. The company has a market cap of $4.29 billion, a price-to-earnings ratio of 30.60, a PEG ratio of 1.51 and a beta of 0.85. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.22 and a quick ratio of 4.22.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.65%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Healthcare REIT's payout ratio is presently 203.39%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the sale, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. The trade was a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.20% of the stock is owned by company insiders.

Institutional Trading of Sabra Healthcare REIT

A hedge fund recently raised its stake in Sabra Healthcare REIT stock. Focus Partners Wealth lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 11.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,146 shares of the real estate investment trust's stock after buying an additional 2,375 shares during the quarter. Focus Partners Wealth's holdings in Sabra Healthcare REIT were worth $404,000 as of its most recent filing with the Securities and Exchange Commission. 99.40% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Scotiabank lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $19.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.